×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Events
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Skin Cancer

Barbara Tako
What can cancer survivors do to cope and process the scale of the COVID-19 pandemic? 
Barbara Tako
Breast cancer and melanoma cancer survivor learned that a combination of changes helped her beat fatigue after cancer treatments.
Jessica Skarzynski
Here are the top five CURE® stories for February 2020.
Ryan McDonald
Men who identify as gay or bisexual report having more skin cancers than those who identify as heterosexual. More frequent use of indoor tanning could be a cause, but researchers want to find out for sure.
 
Jessica Skarzynski
In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Lainie Jones, who has found her purpose in helping others after being diagnosed with five separate primary cancers before the age of 35 because of a rare genetic condition that predisposes her to develop the disease.
 
Beth Fand Incollingo
From Neil Peart’s passing following a battle with brain cancer to a new online support group for men with testicular cancer, here’s the news making an impact in the cancer landscape.
Conor Killmurray
Patients with stage 3 melanoma who had one or more circulating tumor cells were found to relapse sooner, providing physicians with an important biomarker to treat the likelihood of relapse.
Perspectives on treatment decision-making in cutaneous squamous cell carcinoma, particularly regarding who is involved in selecting therapy.
Dr. Todd Schlesinger shares his experience with cemiplimab, an immunotherapy agent used to treat cutaneous squamous cell carcinoma.
 
Considerations for the use of immunotherapy, a novel approach to treatment, in patients with cutaneous squamous cell carcinoma.
 
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×